Who invested in Maven Clinic?
Maven Clinic's investors include BoxGroup, StepStone Group, Sequoia Capital, General Catalyst and Lux Capital, and 11 more on record. StepStone Group led its latest round.

United States · Series F startup
3 rounds we have observed, with the 16 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Valuation: $1.0B, Oct 2024
Follow Maven Clinic and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$127Mraised across 3 rounds since 2015, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by TechStartups and 3 others
No investor was named in the report.
From a historical funding recordSEC filing: $2.3M sold, first sale Jun 2014
From a historical funding recordSEC filing: $2.3M sold, first sale Jun 2014
Maven Clinic filed 3 raises, $18M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Maven Clinic's own website and the SEC filings it signed: 1 founder, 7 on the team.
On the board, as filediLauren Brueggen
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Maven Clinic's investors include BoxGroup, StepStone Group, Sequoia Capital, General Catalyst and Lux Capital, and 11 more on record. StepStone Group led its latest round.
Maven Clinic has raised $127M across 3 rounds since 2015. One round did not disclose an amount, so the total is a floor.
Maven Clinic's most recent round was a Series F of $125M in Oct 2024, led by StepStone Group.
Its most recent round, $125M in Oct 2024, is also its largest on record.
Maven Clinic's first round on record, in Apr 2015, was backed by BoxGroup, Great Oaks Venture Capital and Venrex and 4 others.
Maven Clinic's latest named round is a Series F, in Oct 2024.
Maven Clinic is based in the United States.
StepStone Group led the Series F in 2024.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.